The present invention provides Bruton's Tyrosine Kinase (Btk) inhibitor compounds according to Formula I, or pharmaceutically acceptable salts thereof, Formula I or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of Btk inhibitor compounds of Formula I in the treatment of Btk mediated disorders.
本发明提供布鲁顿
酪氨酸激酶(Btk)
抑制剂化合物,根据公式I,或其药用可接受的盐,公式I,或包含这些化合物的药物组合物,以及它们在治疗中的用途。特别是,本发明涉及在治疗Btk介导的疾病中使用公式I的Btk
抑制剂化合物。